![]() EyePoint Pharmaceuticals EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness. | ||
Founding Date | Founding Date 1895 | Founding Date 1987 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Bad Vilbel, DE HQ Beijing, CN Hangzhou Shi, CN Shanghai, CN Bad Vilbel, DE Budapest, HU Vilnius, LT see more | Locations Watertown, US HQ |
Employees | Employees 12,33911% increase | Employees 8453% increase |
Valuation ($) | Valuation ($) 6 b | Valuation ($) 617.6 m |
Financial | ||
Revenue (est.) | Revenue (est.) €3b (FY, 2020) | Revenue (est.) $31.4m (FY, 2025) |
Net income | Net income €181.9m (FY, 2020) | Net income ($232m) (FY, 2025) |

EyePoint Pharmaceuticals (formerly pSivida) is a pharmaceutical company focused on the development of innovative miniaturized, sustained-release drug delivery products and technologies to treat serious, debilitating diseases of the eye that can lead to blindness.
View company